Radiation for High-Risk Breast Cancer After Chemotherapy
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
- Age
- 18 – 75
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 722 (estimated)
- Sponsor
- Fujian Medical University Union Hospital · Other
This trial is looking for women who have high-risk breast cancer after chemotherapy. Participants will receive radiation therapy aimed at specific lymph nodes to see if it helps improve their chances of staying cancer-free.
You may be able to join if
- I have been diagnosed with invasive breast cancer.
- I have completed neoadjuvant chemotherapy.
- I am willing to follow up with the study.
- I have experienced lymph node involvement after chemotherapy or had specific lymph node metastasis before treatment.
- I am in good enough health with a performance status of 0-2.
- I have no distant metastases.
- I have no internal mammary node metastases based on previous imaging.
You may not be able to join if
- I have not undergone neoadjuvant chemotherapy.
- I have distant metastases.
- I have simultaneous bilateral breast cancer.
- I have had lymph node metastasis in the internal mammary before treatment.
- I have a history of certain other cancers, unless they are non-malignant or specific types.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe aim of this study is to explore the impact of internal mammary nodal irradiation on disease-free survival in high-risk breast cancer patients (ypN+or supra/subclavicular lymph node positive) after neoadjuvant chemotherapy.
Loading trial locations…